Advertisement

Liver

  • M. Elizabeth Oates
  • Vincent L. Sorrell
Chapter

Abstract

The hepatobiliary system is the primary route of clearance of the99mTc MPI radiopharmaceuticals. The degree of liver visualization depends on liver function, composition (e.g., scarring), interval between radiopharmaceutical administration and imaging, and type of stress performed. Liver shape and size can be readily evaluated. The degree of uptake within a hepatic neoplasm is variable, and lesions can appear “hot” or “cold.” Localized hepatic activity adjacent to the (nonfilling) gallbladder fossa may signal complicated acute cholecystitis.

Keywords

Hepatic Neoplasm Primary Route Hepatobiliary System Polycystic Liver Disease Gallbladder Fossa 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Supplementary material

330381_1_En_19_MOESM1_ESM.avi (3 mb)
Fig. 19.1a (AVI 3108 kb)
330381_1_En_19_MOESM2_ESM.avi (3 mb)
Fig. 19.1b (AVI 3108 kb)
330381_1_En_19_MOESM3_ESM.mp4 (361 kb)
Fig. 19.1c (MP4 361 kb)
Fig. 19.1d

(AVI 92800 kb)

330381_1_En_19_MOESM5_ESM.avi (4.2 mb)
Fig. 19.2 (AVI 4307 kb)
330381_1_En_19_MOESM6_ESM.avi (3 mb)
Fig. 19.3a (AVI 3108 kb)
330381_1_En_19_MOESM7_ESM.avi (3 mb)
Fig. 19.3b (AVI 3108 kb)
330381_1_En_19_MOESM8_ESM.avi (3 mb)
Fig. 19.3c (AVI 3108 kb)
330381_1_En_19_MOESM9_ESM.avi (3 mb)
Fig. 19.4a (AVI 3108 kb)
330381_1_En_19_MOESM10_ESM.mp4 (332 kb)
Fig. 19.4b (MP4 332 kb)
330381_1_En_19_MOESM11_ESM.avi (3 mb)
Fig. 19.4c (AVI 3108 kb)
Fig. 19.4d

(AVI 58992 kb)

330381_1_En_19_MOESM13_ESM.avi (10.6 mb)
Fig. 19.4e (AVI 10806 kb)
330381_1_En_19_MOESM14_ESM.mp4 (1.1 mb)
Fig. 19.4f (MP4 1100 kb)
330381_1_En_19_MOESM15_ESM.avi (6.3 mb)
Fig. 19.5a (AVI 6490 kb)
330381_1_En_19_MOESM16_ESM.avi (6.5 mb)
Fig. 19.5b (AVI 6628 kb)
330381_1_En_19_MOESM17_ESM.mp4 (1.3 mb)
Fig. 19.5c (MP4 1295 kb)
330381_1_En_19_MOESM18_ESM.avi (12.9 mb)
Fig. 19.6a (AVI 13254 kb)
330381_1_En_19_MOESM19_ESM.avi (23.1 mb)
Fig. 19.6b (AVI 23700 kb)
330381_1_En_19_MOESM20_ESM.avi (7.9 mb)
Fig. 19.7a (AVI 8077 kb)
330381_1_En_19_MOESM21_ESM.avi (5.5 mb)
Fig. 19.7b (AVI 5594 kb)
330381_1_En_19_MOESM22_ESM.mp4 (831 kb)
Fig. 19.7c (MP4 832 kb)
330381_1_En_19_MOESM23_ESM.mp4 (544 kb)
Fig. 19.7d (MP4 544 kb)
330381_1_En_19_MOESM24_ESM.avi (11.2 mb)
Fig. 19.7e (AVI 11442 kb)
330381_1_En_19_MOESM25_ESM.avi (3 mb)
Fig. 19.8a (AVI 3108 kb)
330381_1_En_19_MOESM26_ESM.avi (3 mb)
Fig. 19.8b (AVI 3108 kb)
330381_1_En_19_MOESM27_ESM.mp4 (338 kb)
Fig. 19.8c (MP4 338 kb)
330381_1_En_19_MOESM28_ESM.mp4 (348 kb)
Fig. 19.8d (MP4 348 kb)
330381_1_En_19_MOESM29_ESM.avi (111.1 mb)
Fig. 19.9a (AVI 113786 kb)
330381_1_En_19_MOESM30_ESM.mp4 (3 mb)
Fig. 19.1c (MP4 3069 kb)

References

  1. Bhambhvani P, Dubovsky E, Nath H, Heo J, Iskandrian A. Unusual incidental findings by SPECT myocardial perfusion imaging and CT in the same patient. J Nucl Cardiol. 2010a;17(5):937–8. doi: 10.1007/s12350-010-9219-1.CrossRefPubMedGoogle Scholar
  2. Bhambhvani P, Dubovsky E, Heo J, Iskandrian A. Incidental detection of hepatocellular carcinoma by SPECT myocardial perfusion imaging. J Nucl Cardiol. 2010b;17(6):1116–7. doi: 10.1007/s12350-010-9267-6.CrossRefPubMedGoogle Scholar
  3. Burrell S, MacDonald A. Artifacts and pitfalls in myocardial perfusion imaging. J Nucl Med Technol. 2006;34:193–211.PubMedGoogle Scholar
  4. Chamarthy M, Travin MI. Altered biodistribution and incidental findings on myocardial perfusion imaging. Semin Nucl Med. 2010;40:257–70.CrossRefPubMedGoogle Scholar
  5. Chatziioannou SN, Alfaro-Franco C, Moore WH, Alanis-Williams L, Dhekne RD, Ford PV. The significance of incidental noncardiac findings in Tc-99m sestamibi myocardial perfusion imaging: illustrated by a case. Tex Heart Instit J. 1999;26:229–31.Google Scholar
  6. Fukushima K, Kono M, Ishii K, Sakai E, Hirota S, Yuri H. Technetium-99m methoxyisobutylisonitrile single-photon emission tomography in hepatocellular carcinoma. Eur J Nucl Med. 1997;24(11):1426–8.CrossRefPubMedGoogle Scholar
  7. Gedik GK, Ergun EL, Aslan M, Caner B. Unusual extracardiac findings detected on myocardial perfusion single photon emission computed tomography studies with Tc-99m sestamibi. Clin Nucl Med. 2007;32:920–6.CrossRefPubMedGoogle Scholar
  8. Ghanbarinia A, Chandra S, Chhabra K, Jain D. Renal abnormalities as incidental findings on myocardial single photon emission computed tomography perfusion imaging. Nucl Med Commun. 2008;29(7):588–92. doi: 10.1097/MNM.0b013e3282f8148b.CrossRefPubMedGoogle Scholar
  9. Hardebeck CJ, Herman C, Auseon A. Identification of incidental hepatic malignancy as photopenic defect on 99mTc-sestamibi myocardial perfusion imaging. Clin Nucl Med. 2013;38(10):821–2. doi: 10.1097/RLU.0b013e31829af8f9.CrossRefPubMedGoogle Scholar
  10. Howarth DM, Forstrom LA, O’Connor MK, Thomas PA, Cardew AP. Patient-related pitfalls and artifacts in nuclear medicine imaging. Semin Nucl Med. 1996;26:295–307.CrossRefPubMedGoogle Scholar
  11. Joy PS, Chhabra A, Ghanbarinia A, Jain D. Extracardiac abnormalities on myocardial perfusion imaging in a patient undergoing liver transplantation. J Nucl Cardiol. 2007;14:126–8.CrossRefPubMedGoogle Scholar
  12. Lamont AE, Joyce JM, Grossman SJ. Acute cholecystitis detected on a Tc-99m sestamibi myocardial imaging. Clin Nucl Med. 1996;21:879.CrossRefPubMedGoogle Scholar
  13. Raza M, Meesala M, Jain D. Unusual radiotracer uptake in the lower mediastinum on sestamibi perfusion images. J Nucl Cardiol. 2005a;12:740–1.CrossRefPubMedGoogle Scholar
  14. Raza M, Meesala M, Panjrath GS, Ghanbarinia A, Jain D. Abnormal photopenic area on nuclear perfusion imaging. J Nucl Cardiol. 2005b;12:607–9.CrossRefPubMedGoogle Scholar
  15. Shih WJ, Kiefer V, Gross K, Wierzbinski B, Collins J, Pulmano C, Ryo YU. Intrathoracic and intra-abdominal Tl-201 abnormalities seen on rotating raw cine data on dual radionuclide myocardial perfusion and gated SPECT. Clin Nucl Med. 2002;27:40–4.CrossRefPubMedGoogle Scholar
  16. Shih WJ, McFarland KA, Kiefer V, Wierzbinski B. Illustrations of abdominal abnormalities on 99mTc tetrofosmin gated cardiac SPECT. Nucl Med Commun. 2005;26:119–27.CrossRefPubMedGoogle Scholar
  17. Tallaj JA, Kova D, Iskandrian AE. The use of technetium-99m sestamibi in a patient with liver cirrhosis. J Nucl Cardiol. 2000;7:722–3.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  • M. Elizabeth Oates
    • 1
  • Vincent L. Sorrell
    • 2
  1. 1.Division of Nuclear Medicine and Molecular Imaging Department of RadiologyUniversity of KentuckyLexingtonUSA
  2. 2.Division of Cardiovascular Medicine Department of Internal Medicine Gill Heart InstituteUniversity of KentuckyLexingtonUSA

Personalised recommendations